dr. Sander Lefere
- ORCID iD
- 0000-0001-5734-3467
Show
Sort by
-
- Journal Article
- A1
- open access
Noninvasive scores are poorly predictive of histological fibrosis in paediatric fatty liver disease
-
Ultra-processed food intake does not correlate with pediatric MASLD in the National Health and Nutrition Examination Survey
(2024) -
- Journal Article
- A1
- open access
Osteopontin characterizes bile duct-associated macrophages and correlates with liver fibrosis severity in primary sclerosing cholangitis
-
Systematic review : glycomics as diagnostic markers for hepatocellular carcinoma
-
Diagnosis of fatty liver in children should occur in parallel to investigation for other causes of liver disease
-
- Miscellaneous
- open access
‘A radical operation’ : a thematic analysis of newspaper framing of bariatric surgery in adolescents (vol 23, 447, 2023)
-
Transient Kupffer cell depletion and subsequent replacement by infiltrating monocyte-derived cells does not alter the induction or progression of hepatocellular carcinoma
-
Patients hospitalized with alcohol-related liver disease and prior bariatric surgery are more prone to develop acute-on-chronic liver failure
-
- Journal Article
- A1
- open access
‘A radical operation’ : a thematic analysis of newspaper framing of bariatric surgery in adolescents
-
- Journal Article
- A1
- open access
Meta-analysis : the impact of light-to-moderate alcohol consumption on progressive non-alcoholic fatty liver disease
-
- Journal Article
- A1
- open access
Reply
-
- Journal Article
- A1
- open access
Bariatric surgery for NAFLD : indications and post-operative management
-
- Journal Article
- A1
- open access
Kupffer cells contested as early drivers in the pathogenesis of primary sclerosing cholangitis
-
Glycomics-based serum markers as reliable tool for assessment of viral response after treatment with direct-acting antiviral drugs in hepatitis C virus infection
-
Neurometabolic and gliovascular changes in murine hepatic encephalopathy
-
Adipose tissue insulin resistance is a determinant of disease severity in pediatric nonalcoholic fatty liver disease
-
Glycomics-based serum marker as reliable tool for assessment of viral response after treatment with direct-acting antiviral drugs in hepatitis C virus infection
-
- Miscellaneous
- open access
MD2 AMP(K)s up the link between lipid accumulation and inflammation in NAFLD COMMENT
-
- Journal Article
- A1
- open access
Combined therapy with a CCR2/CCR5 antagonist and FGF21 analogue synergizes in ameliorating steatohepatitis and fibrosis
-
- Journal Article
- A1
- open access
A mouse model of hepatic encephalopathy : bile duct ligation induces brain ammonia overload, glial cell activation and neuroinflammation.
-
Perinatal risk factors for pediatric nonalcoholic fatty liver disease : impact of inborn errors of metabolism : reply
-
- Journal Article
- A1
- open access
Maternal and perinatal risk factors for pediatric nonalcoholic fatty liver disease : a systematic review
-
- Journal Article
- A1
- open access
Intensive lifestyle management improves steatosis and fibrosis in pediatric non-alcoholic fatty liver disease
-
Metallothioneins alter macrophage phenotype and represent novel therapeutic targets for acetaminophen-induced liver injury
-
Intensive lifestyle management improves steatosis and fibrosis in pediatric metabolic-associated fatty liver disease
-
- Journal Article
- A2
- open access
Characterization of the inflammatory microenvironment and hepatic macrophage subsets in experimental hepatocellular carcinoma models
-
- Journal Article
- A1
- open access
The neurogliovascular unit in hepatic encephalopathy
-
Bariatric surgery and the liver : mechanisms, benefits, and risks
-
Myeloid IRE1a deletion alters hepatic macrophage phenotype and attenuates experimental non-alcoholic steatohepatitis-related hepatocellular carcinoma
-
Targeting CCR2/5 in the treatment of nonalcoholic steatohepatitis (NASH) and fibrosis : opportunities and challenges
-
Angiogenesis in the progression of non-alcoholic fatty liver disease
-
- Journal Article
- A2
- open access
Effect of isoform-specific HIF-1α and HIF-2α antisense oligonucleotides on tumorigenesis, inflammation and fibrosis in a hepatocellular carcinoma mouse model
-
- Conference Paper
- C3
- open access
A murine model of hepatic encephalopathy : validation and neurobehavioral testing
-
- Journal Article
- A1
- open access
The angiopoietin/tie2 pathway in hepatocellular carcinoma
-
Differential effects of selective- and pan-PPAR agonists on experimental steatohepatitis and hepatic macrophages
-
Bariatric surgery patients are at risk for alcoholic liver disease with need for liver transplantation
-
- Journal Article
- A2
- open access
Lighter serum copper isotopic composition in patients with early non-alcoholic fatty liver disease
-
Myeloid-specific IRE1alpha deletion reduces tumour development in a diabetic, non-alcoholic steatohepatitis-induced hepatocellular carcinoma mouse model
-
Combination of sivelestat and N-acetylcysteine alleviates the inflammatory response and exceeds standard treatment for acetaminophen-induced liver injury
-
Angiogenesis and macrophages as diagnostic and therapeutic targets in non-alcoholic fatty liver disease
(2019) -
- Journal Article
- A1
- open access
Macrophages in obesity and non-alcoholic fatty liver disease : crosstalk with metabolism
-
Unveiling the depletion of Kupffer cells in experimental hepatocarcinogenesis through liver macrophage subtype-specific markers
-
Myeloid-specific IRE1 alpha deletion reduces tumour development in a non-alcoholic steatohepatitis-induced hepatocellular carcinoma mouse model
-
Angiopoietin-2 promotes pathological angiogenesis and is a therapeutic target in murine nonalcoholic fatty liver disease
-
The combination of N-acetylcysteine and anti-MT antibodies as novel therapy for acetaminophen-induced liver injury
-
Angiopoietin-2 as therapeutic target for pathological angiogenesis and inflammation in non-alcoholic steatohepatitis
-
Angiopoietin-2 as therapeutic target for pathological angiogenesis and inflammation in non-alcoholic steatohepatitis
-
- Conference Paper
- C3
- open access
Angiopoietin-2 promotes pathological angiogenesis and is a novel therapeutic target in non-alcoholic fatty liver disease
-
Placental growth factor inhibition targets pulmonary angiogenesis and represents a therapy for hepatopulmonary syndrome in mice
-
Serum vascular cell adhesion molecule-1 predicts significant liver fibrosis in obese patients with non-alcoholic fatty liver disease